Biotech Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), Questcor Pharmaceuticals(NASDAQ:QCOR), Seattle Genetics (NASDAQ:SGEN), Repligen Corporation (NASDAQ:RGEN), bluebird bio (NASDAQ:BLUE)

Achillion Pharmaceuticals Inc (NASDAQ:ACHN) major shareholder Qvt Associates Gp Llc sold 128,649 shares of the company’s stock in a transaction dated Wednesday, June 11th. The shares were sold at an average price of $7.66, for a total transaction of $985,451.34. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was -6.32% in last session and finished the day at $6.38. Traded volume was 21.04million shares in the last … Continue reading Biotech Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), Questcor Pharmaceuticals(NASDAQ:QCOR), Seattle Genetics (NASDAQ:SGEN), Repligen Corporation (NASDAQ:RGEN), bluebird bio (NASDAQ:BLUE)

Biotech Insider Buying: Seattle Genetics (NASDAQ:SGEN), Corcept Therapeutics Incorporated (NASDAQ:CORT), Cytori Therapeutics (NASDAQ:CYTX), Oramed Pharmaceuticals (NASDAQ:ORMP), Biota Pharmaceuticals (NASDAQ:BOTA)

Seattle Genetics, Inc (NASDAQ:SGEN) Director Felix Baker purchased 281,963 shares of Seattle Genetics stock in a transaction dated Wednesday, June 4th. The stock was purchased at an average price of $34.86 per share, for a total transaction of $9,829,230.18. Following the transaction, the director now directly owns 76,997 shares of the company’s stock, valued at approximately $2,684,115. Seattle Genetics, Inc. (NASDAQ:SGEN) stock performance was -0.05% … Continue reading Biotech Insider Buying: Seattle Genetics (NASDAQ:SGEN), Corcept Therapeutics Incorporated (NASDAQ:CORT), Cytori Therapeutics (NASDAQ:CYTX), Oramed Pharmaceuticals (NASDAQ:ORMP), Biota Pharmaceuticals (NASDAQ:BOTA)

NASDAQ Insider Buying: Bazaarvoice Inc (NASDAQ:BV), Seattle Genetics (NASDAQ:SGEN), Corcept Therapeutics Incorporated (NASDAQ:CORT), Career Education (NASDAQ:CECO), Acorn Energy (NASDAQ:ACFN)

Bazaarvoice Inc (NYSE:BV) President Eugene Austin purchased 10,000 shares of the company’s stock on the open market in a transaction dated Monday, June 9th. The stock was purchased at an average price of $7.05 per share, with a total value of $70,500.00. Following the acquisition, the president now directly owns 260,000 shares in the company, valued at approximately $1,833,000. Bazaarvoice Inc (NASDAQ:BV) stock performance was … Continue reading NASDAQ Insider Buying: Bazaarvoice Inc (NASDAQ:BV), Seattle Genetics (NASDAQ:SGEN), Corcept Therapeutics Incorporated (NASDAQ:CORT), Career Education (NASDAQ:CECO), Acorn Energy (NASDAQ:ACFN)

Mid Cap Insider Buying: Noble Corp. (NYSE:NE), WPX Energy (NYSE:WPX), DSW (NYSE:DSW), Opko Health (NYSE:OPK), Seattle Genetics (NASDAQ:SGEN)

Noble Co. (NYSE:NE) CEO David W. Williams bought 10,000 shares of the stock on the open market in a transaction that occurred on Friday, June 6th. The stock was purchased at an average price of $31.03 per share, with a total value of $310,300.00. Following the completion of the purchase, the chief executive officer now directly owns 390,282 shares of the company’s stock, valued at … Continue reading Mid Cap Insider Buying: Noble Corp. (NYSE:NE), WPX Energy (NYSE:WPX), DSW (NYSE:DSW), Opko Health (NYSE:OPK), Seattle Genetics (NASDAQ:SGEN)

Gilead Sciences GILD NASDAQ:GILD

Biotech Losers: MannKind Corporation (NASDAQ:MNKD), Rexahn Pharmaceuticals (NYSEMKT:RNN), ZIOPHARM Oncology (NASDAQ:ZIOP), Seattle Genetics (NASDAQ:SGEN)

MannKind Corporation (NASDAQ:MNKD) announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for AFREZZA(R) by three months to July 15, 2014 in order to provide time for a full review of information submitted by MannKind in response to the FDA’s requests.MannKind Corporation (NASDAQ:MNKD) stock performance was -6.42% in last session and finished the day at … Continue reading Biotech Losers: MannKind Corporation (NASDAQ:MNKD), Rexahn Pharmaceuticals (NYSEMKT:RNN), ZIOPHARM Oncology (NASDAQ:ZIOP), Seattle Genetics (NASDAQ:SGEN)

Top News: United States Steel Corp. (NYSE:X), Seattle Genetics Inc. (NASDAQ:SGEN), Naugatuck Valley Financial Corporation (NASDAQ:NVSL), National CineMedia (NASDAQ:NCMI), SK Telecom (NYSE:SKM)

On Oct 28, United States Steel Corp. (NYSE:X) posted a narrower loss, as revenue increased and the company said U.S. market conditions have remained stable. For the quarter ended Sept. 30, the company posted a loss of $207 million, or $1.42 a share, compared with a loss of $1.79 billion, or $12.38 a share, a year earlier, which reflected a $1.78 billion impairment charge. United … Continue reading Top News: United States Steel Corp. (NYSE:X), Seattle Genetics Inc. (NASDAQ:SGEN), Naugatuck Valley Financial Corporation (NASDAQ:NVSL), National CineMedia (NASDAQ:NCMI), SK Telecom (NYSE:SKM)